Two Sigma Investments
ADMA icon

Two Sigma Investments’s ADMA Biologics ADMA Stock Holding History

Two Sigma Investments’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.9M Buy
2,092,133
+1,587,959
+315% +$25.1M 0.02% 983
2025
Q4 		$9.2M Sell
504,174
-393,854
-44% -$6.64M 0.01% 1184
2025
Q3 		$13.2M Sell
898,028
-304,073
-25% -$5.21M 0.02% 816
2025
Q2 		$21.9M Sell
1,202,101
-1,053,205
-47% -$21.5M 0.04% 521
2025
Q1 		$44.7M Sell
2,255,306
-293,648
-12% -$5.08M 0.1% 262
2024
Q4 		$43.7M Sell
2,548,954
-1,042,421
-29% -$19.6M 0.1% 257
2024
Q3 		$71.8M Sell
3,591,375
-436,225
-11% -$6.78M 0.16% 156
2024
Q2 		$45M Buy
4,027,600
+181,642
+5% +$1.52M 0.1% 229
2024
Q1 		$25.4M Buy
3,845,958
+740,948
+24% +$4.05M 0.06% 370
2023
Q4 		$14M Sell
3,105,010
-82,734
-3% -$306K 0.03% 542
2023
Q3 		$11.4M Buy
3,187,744
+397,741
+14% +$1.53M 0.03% 560
2023
Q2 		$10.3M Buy
2,790,003
+468,644
+20% +$1.74M 0.03% 637
2023
Q1 		$7.68M Sell
2,321,359
-67,125
-3% -$232K 0.02% 704
2022
Q4 		$9.27M Buy
2,388,484
+1,062,502
+80% +$3.28M 0.03% 587
2022
Q3 		$3.22M Buy
1,325,982
+764,545
+136% +$1.83M 0.01% 947
2022
Q2 		$1.11M Buy
+561,437
New +$1.1M ﹤0.01% 1497
2020
Q1 		– Sell
-25,453
Closed -$102K – 3007
2019
Q4 		$102K Buy
+25,453
New +$111K ﹤0.01% 3519
2019
Q3 		– Sell
-54,334
Closed -$210K – 3398
2019
Q2 		$210K Buy
+54,334
New +$240K ﹤0.01% 3061

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Two Sigma Investments's ADMA Position: Q1 2026 in Review

Two Sigma Investments increased its ADMA Biologics (ADMA) stake by 315% in Q1 2026, buying an estimated $25.1M and bringing the position to 2,092,133 shares worth $18.9M. The position accounts for 0.02% of the portfolio, ranked #983.

Two Sigma Investments first reported a position in ADMA in Q2 2019 and has held it in 18 quarters since. The position peaked at $71.8M in Q3 2024. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Two Sigma Investments held 2,092,133 shares of ADMA Biologics worth $18.9M as of Q1 2026.
  • Two Sigma Investments bought 1,587,959 ADMA Biologics shares in Q1 2026, an estimated $25.1M.
  • ADMA Biologics made up 0.02% of Two Sigma Investments's portfolio in Q1 2026, its #983 holding.
  • Two Sigma Investments first reported a position in ADMA Biologics in Q2 2019 and has held it in 18 quarters since.
  • Two Sigma Investments's ADMA Biologics position peaked at $71.8M in Q3 2024.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.